drugset / Trial / NCT06720467

Immunotherapy in Eyelid Viral Papilloma

NCT06720467

Phase 2 Completed 22 enrolled Zagazig University
NaSingle-groupOpen-labelTreatment

Summary

intralesional injection of Candida antigens for treating eyelid warts is supposed to have less destructive effect than other surgical interventions

Timeline

Start
2024-06-11
Primary completion
2025-03-15
Completion
2025-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Candida albicans antigen Unknown 0.2 ml Other

Indications